These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6180229)

  • 1. [Results of discussions of fibrinogen B].
    Morozova VT
    Lab Delo; 1982; (6):30-1. PubMed ID: 6180229
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 3. [2 simple methods of detecting fibrin degradation products in blood].
    Gabitov SZ; Voronina IE; Litvinov RI
    Lab Delo; 1982; (6):34-6. PubMed ID: 6180231
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative fibrinogen determination by artificial in vitro fibrinogen lysis with regard to fibrinogen split products].
    Kätzel R; Brunner HP; Bohr A
    Z Med Lab Diagn; 1981; 22(3):138-43. PubMed ID: 7293326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 8. Tanned red cell haemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products.
    Kings GL; Stoodley KD
    Med Lab Sci; 1980 Oct; 37(4):317-22. PubMed ID: 7207041
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.
    McCarron BI; Marder VJ; Francis CW
    Thromb Haemost; 1999 Dec; 82(6):1722-9. PubMed ID: 10613661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative immunoenzyme method for determining fibrin-fibrinogen degradation products in the blood].
    Ermolin GA; Liusov VA; Panchenko EP
    Lab Delo; 1984; (1):11-5. PubMed ID: 6199554
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparation and characterization of NH2-terminal fibrinogen B beta fragments from N-DSK of human fibrinogen.
    Birken S; Agosto G; Lahiri B; Canfield R
    Thromb Haemost; 1984 Feb; 51(1):16-21. PubMed ID: 6232727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinogen degradation products in diabetes mellitus].
    Bondar PN
    Vrach Delo; 1981 Oct; (10):80-1. PubMed ID: 7303588
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic efficacy of estimating fibrinogen/fibrin degradation products in pleural and peritoneal effusion fluids.
    Dube B; Narayanan R; Dube RK; Singh VP
    J Assoc Physicians India; 1984 Jun; 32(6):493-5. PubMed ID: 6511725
    [No Abstract]   [Full Text] [Related]  

  • 14. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)].
    Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H
    Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress in the measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Clin Pathol; 1984; 9():15-45. PubMed ID: 6229812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Products of fibrinogen degradation in cirrhotic ascites. Value of their assay].
    Hadchouel P; Bognel JC; Caillet R; Perotin B; Hebert D
    Nouv Presse Med; 1980 Jun; 9(26):1844. PubMed ID: 7393737
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemical discrimination of leukocyte elastase from plasmic degradation products of fibrinogen.
    Plow EF; Gramse M; Havemann K
    J Lab Clin Med; 1983 Dec; 102(6):858-69. PubMed ID: 6227673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin degradation products in acute myocardial infarction.
    Arya TV; Goel VK; Mehrotra TN; Singh VS; Rajvanshi S; Raka MS
    J Assoc Physicians India; 1983 Nov; 31(11):691-2. PubMed ID: 6671945
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of fibrinogen degradation products in rheumatic diseases].
    Murav'ev IuV
    Ter Arkh; 1980; 52(6):84-7. PubMed ID: 7404395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.